Key facts
- Astromech (Discovery Tools)’s last known valuation is $125.0M (Aug 2025).
- It has raised $40.5M; the latest was Seed Round ($10.5M) in Mar 2026.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Astromech (Discovery Tools)
- ·The full record, as it builds
Funding rounds
No funding rounds for Astromech (Discovery Tools) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Astromech (Discovery Tools)
Developer of biological intelligence systems designed to model and interpret evolutionary and genomic processes. The company's platform integrates transcriptomic analysis, pangenome modeling, multi-omics data, and deep learning for functional recognition, emphasizes continuous updates and structured biological insights, and supports therapeutic development and trait optimization, enabling researchers and institutions to decode regulatory logic, predict evolutionary patterns, and advance medicine, agriculture, and synthetic biology with robust data-driven frameworks.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2025
- Website
- astromech.com/
- Ownership
- Privately Held (backing)
Astromech (Discovery Tools) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Astromech (Discovery Tools) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Astromech (Discovery Tools) in its N-PORT filings yet. We sweep new filings monthly.